Understanding life

Next Generation Proteomics Solutions

Faster Analysis - Deeper Coverage - Better Experience

Unsurpassed Performance for DDA Proteomics with SpectroMine 2

Understanding life

Next Generation Proteomics Solutions

Large Scale Proteomics

Unprecedented depth and reproducibility over thousands of samples measured across large sample cohorts make Biognosys the partner of choice for large-scale studies.

Understanding life

Next Generation Proteomics Solutions

Drug Target Deconvolution

Limited Proteolysis coupled with next-generation Mass Spectrometry (LiP-MS) can directly identify protein drug targets and characterize their binding properties.

Understanding life

Next Generation Proteomics Solutions

Deep Proteomics in Depleted Plasma

Our deep plasma/serum profiling workflow enables robust and reproducible discovery and quantification of 1’000+ proteins in large-scale studies.

Home / Biognosys - Next Generation Proteomics

Biognosys - Next Generation Proteomics

Why proteomics?

Proteomics aims at understanding the proteome by enabling the unbiased and large-scale study of proteins. Watch the video to understand why next generation proteomics should be the technology of choice in studies involving multiplexed protein quantification.

Biognosys Services

We provide services for high-content protein quantification from any species in any biological matrix.

Click to learn more about our services.

 

Biognosys Products

For researchers with access to mass spectrometers we offer a variety of tools that empower researchers to bring next-generation proteomics in-house.

Click to learn more about our products.

 

Biognosys Technology

Biognosys is the leading proteomics company offering services and tools for highly multiplexed protein quantification.

Click to learn more about our technology.

 

Biognosys Online Shop

You are welcome to purchase our standardized products for Next-Generation Proteomics in our online shop.

Click to go to the online shop.

 
BIOGNOSYS

NEWS

11 November 2020

What is Proteomics?

27 August 2020

New Nature Communications publication in collaboration with ETH Zurich, Bayer, and BASF

27 August 2020

Biognosys Announces Nature Communications Publication in Collaboration with ETH Zurich, Bayer, and BASF

23 July 2020

Boehringer Ingelheim and Biognosys Join Forces on Applying Quantitative Proteomics Tools in Drug Discovery

17 June 2020

Biognosys Announces Appointment of Dr. Patrick Vink as Chairman
 Go to news archive.
BIOGNOSYS

EVENTS

9
November SITC
 Go to conference calendar
×

Let us help you do great proteomics!

Please click here to contact us.